HeimBIOG-B • STO
add
BioGaia AB
Við síðustu lokun
108,40 kr.
Dagbil
107,20 kr. - 108,80 kr.
Árabil
93,45 kr. - 136,60 kr.
Markaðsvirði
10,56 ma. SEK
Meðalmagn
318,34 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
STO
Viðskiptafréttir
WSJ
fyrir 1 klukkustund
Stock Market News, Oct. 9, 2024: Dow, S&P 500 Rise to Records; Oil Prices
Slip
1,03%
0,71%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (SEK) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 384,12 m. | 21,86% |
Rekstrarkostnaður | 142,86 m. | 2,14% |
Nettótekjur | 111,01 m. | 37,82% |
Hagnaðarhlutfall | 28,90 | 13,11% |
Hagnaður á hvern hlut | — | — |
EBITDA | 147,33 m. | 58,38% |
Virkt skatthlutfall | 22,24% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (SEK) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,01 ma. | -26,42% |
Heildareignir | 1,90 ma. | -11,88% |
Heildarskuldir | 325,40 m. | 19,08% |
Eigið fé alls | 1,58 ma. | — |
Útistandandi hlutabréf | 100,98 m. | — |
Eiginfjárgengi | 6,95 | — |
Arðsemi eigna | 16,11% | — |
Ávöxtun eigin fjár | 18,86% | — |
Peningaflæði
Breyting á handbæru fé
| (SEK) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 111,01 m. | 37,82% |
Handbært fé frá rekstri | 119,12 m. | 13,94% |
Reiðufé frá fjárfestingum | -2,24 m. | 90,87% |
Reiðufé frá fjármögnun | -699,12 m. | -136,40% |
Breyting á handbæru fé | -583,65 m. | -176,28% |
Frjálst peningaflæði | 100,27 m. | 67,38% |
Um
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Framkvæmdastjóri
Stofnsett
1990
Vefsvæði
Starfsfólk
220
